Novo Nordisk shares fell 30% in the fourth quarter on disappointing clinical trial data, concerns about its experimental ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the initiation of ...

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...